FDA clears AI 3D head, neck imaging tech from RapidAI

RapidAI announced that it received FDA 510(k) clearance for its Lumina 3D automated 3D imaging reconstruction solution.

San Mateo, California-based RapidAI designed its platform to replace manual workflows with an AI-powered approach.

The company says manual computed tomography angiography (CTA) reconstructions take considerable time, with turnaround stretched to hours at times. This can delay critical diagnosis and hinder radiologists and neurointerventionalists. Lumina 3D, however, accomplishes this in minutes while running in real-time, according to a news release.

RapidAI says it designed Lumina 3D for large-scale applications, ensuring 24/7 availability for hospitals of all sizes. It engineered the system for speed, accuracy and efficiency to alleviate workloads. The platform also boosts productivity and can accelerate daignosis and treatment processes, the company says.

Sign up for Blog Updates